Medical Oncology clinical trials

Name: REAL PRO

Registry-based Study of Enzalutamide vs Abiraterone assessing cognitive function in ELderly patients with Metastatic Castration-Resistant Prostate Cancer.

Principal Investigator: Dr Malmaruha Arasaratnam
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
More information about REAL PRO

Name: DASL HiCaP

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (ANZUP1801). A randomized phase 3 double-blind, placebo-controlled trial of adding Darolutamide to androgen deprivation therapy and definitive or salvage radiation in very high risk, clinically localised prostate cancer.

Principal Investigator: Dr Craig Kukard
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
 More information about DASL HiCaP

More information

For more information about medical oncology clinical trials, please contact the Nurse Unit Manager on 02 4320 9890 or see:

 Research and Clinical Trials

Radiation Oncology clinical trials

Name: OPTIMAL

Optimal Prostate Fractional Study

Principal Investigator: Prof Andrew Kneebone
Study Coordinator: Abraham Mathews
Status: Recruiting
Condition: Prostate Cancer
More Information about OPTIMAL